Navigation Links
Anti-Retrovirals in Africa, not a distant dream

Ranbaxy Laboratories (India) has entered into a joint venture with a South African company that will support Ranbaxy’s key agenda of enabling antiretroviral drugs in Africa. //A joint venture between Ranbaxy and South Africa based Community Investment Holdings has been signed, that will give authority for this company to sell the drugs in Africa. The CEO of Ranbaxy South Africa, Desmond Brothers, conveyed that this venture will permit the company to make the drugs available at a low cost.

Ranbaxy will retain 70% of the venture, called Sonke Pharmaceuticals, in charge of marketing the products under the brand name 'Sonke'. Governments, retail pharmacists, HIV/AIDS disease management companies, nongovernmental organizations and independent community treatment organizations in South Africa, Botswana and Namibia, will be the contact points for sales of the antiretroviral drugs.


'"/>




Page: 1

Related medicine news :

1. Anti-Retrovirals Capable of Halting Mental Illness in HIV Patients
2. Unilever And World Dental Federation Team Up To Improve Oral Health In North Africa, Middle East and Turkey
3. UC Researchers: Low-cost malaria cure will not be a distant dream
4. Rats dream about running mazes...
5. Adult And Children Cravings: Sleep and More Sleep is a dream!
6. UC Researchers: Low-cost malaria cure will not be a distant dream
7. "Daydreaming" Network Fails In Autism
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... , ... July 24, 2017 , ... A CDC study shows that, although people are ... Caucasians (ages 18 to 29), had at least one case of sunburn within the past ... which causes people to ignore the issue. However, only recently have people become conscientious of ...
(Date:7/24/2017)... ... July 24, 2017 , ... The 2017 NCSL International Workshop ... theme focuses on the new ISO/IEC 17025 standards. This marks the first time ... and calibration will be changed. , As an exhibitor, METTLER TOLEDO will ...
(Date:7/24/2017)... ... July 24, 2017 , ... Paul Vitenas, MD, FACS is excited ... plastic surgeons, invited to attend Allergan’s recent meeting with their Plastics Advisory Board. As ... the world, Allergan is bringing a newly defined structure to the aesthetics market. ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... CURE announced that they have enrolled over 100,000 children in their treatment program. ... born every year in areas where treatment is limited or non-existent. Without intervention, ...
(Date:7/24/2017)... Church, VA (PRWEB) , ... July 24, 2017 ... ... figuring out how to change manufacturers future. , The agency is hammering out ... Cures Act, one of the farthest-ranging laws ever to affect FDA-regulated firms. The ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... plc (NASDAQ: ENDP ) will announce its second-quarter 2017 ... management team will host a conference call and webcast before the ... The dial-in number to access the call is U.S./ Canada ... 45397076. Please dial in 10 minutes prior to the scheduled start ... the call will be available from August 8, 2017 at 11:30 ...
(Date:7/13/2017)... July 13, 2017 RK Logistics Group, Inc. was ... certification for its Fremont, CA headquarters ... the Tri-Valley and San Jose for ... of Fremont , with its Fremont Innovation District, is ... such a powerful resource to the hundreds of biotech, pharma ...
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
Breaking Medicine Technology: